Longer polyglutamine chains have been shown to hinder the transactivation activity of AR in vitro, while short polyglutamine chains lead to enhanced AR activation resulting in hyperandrogenism [46], [57]–[59]. The gene discussed is AR; the disease is hyperandrogenism.